Visual Field Loss in a Case of Recurrent Cystic Craniopharyngioma During Concomitant Treatment With Pegylated Interferon α-2b.
Document Type
Journal Article
Publication Date
1-1-2016
Journal
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology
Volume
38
Issue
1
Inclusive Pages
e26-8
DOI
10.1097/MPH.0000000000000468
Keywords
Adolescent; Antineoplastic Agents; Craniopharyngioma; Cysts; Drug Administration Routes; Humans; Interferon-alpha; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Polyethylene Glycols; Recombinant Proteins; Vision Disorders; Visual Fields
APA Citation
Tiedemann, L., Manley, P., Smith, E., & Dagi, L. (2016). Visual Field Loss in a Case of Recurrent Cystic Craniopharyngioma During Concomitant Treatment With Pegylated Interferon α-2b.. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, 38 (1). http://dx.doi.org/10.1097/MPH.0000000000000468
Peer Reviewed
1
